Affluent Medical : Half-year liquidity contract statement for Affluent Medical.
Affluent Medical Affluent Medical : Half-year liquidity contract statement for Affluent Medical. Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Aix-en-Provence, 5 July 2022 – 5:45 PM
Half-year liquidity contract statement for Affluent Medical
Public limited company with a capital of € 18 163 802 Registered office: 320, avenue Archimède Les Pléiades III - Bâtiment B 13100 Aix-en-Provence France 837 722 560 R.C.S. on the Aix-en-Provence Trade and Companies Register
Under the liquidity contract entered into between Affluent Medical and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2022:
As a reminder:
the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:
the following resources appeared on the liquidity account when the activity started:
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
About Affluent Medical Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the pre-clinical and clinical study phase. Kalios is set to be the first medical device to be marketed in Europe. For more information, please visit: www.affluentmedical.com
Contacts:
Regulatory filing PDF file File: Affluent Medical : Half-year liquidity contract statement. |
|
|
Language: | English |
Company: | Affluent Medical |
320 avenue Archimède, Les pléiades III Bâtiment B | |
13100 Aix en Provence France | |
France | |
Phone: | +33 4 42 95 12 20 |
E-mail: | [email protected] |
Internet: | https://www.affluentmedical.com/ |
ISIN: | FR0013333077 |
Euronext Ticker: | AFME |
AMF Category: | Share buyback / Disposal of own shares / Information relating to the liquidity contract |
EQS News ID: | 1391293 |
End of Announcement | EQS News Service |
|
1391293 05-Jul-2022 CET/CEST